'This added to my multiple myopia'

Por Irwig, Les
Publicado em 2003

Screening for diabetes: what are we really doing?

Por Goyder, Elizabeth, Irwig, Les
Publicado em 1998

Implementing honesty about screening using community informed consent

Por Irwig, Les, Glasziou, Paul
Publicado em 2000

Monitoring in chronic disease: a rational approach

Por Glasziou, Paul, Irwig, Les, Mant, David
Publicado em 2005

Evaluating new screening tests for breast cancer: May require randomised controlled trials to assess overdetection

Por Irwig, Les, Houssami, Nehmat, Armstrong, Bruce, Glasziou, Paul
Publicado em 2006

Informed choice for screening: implications for evaluation

Por Irwig, Les, McCaffery, Kirsten, Salkeld, Glenn, Bossuyt, Patrick
Publicado em 2006

Comparative accuracy: assessing new tests against existing diagnostic pathways

Por Bossuyt, Patrick M, Irwig, Les, Craig, Jonathan, Glasziou, Paul
Publicado em 2006

Long term monitoring in patients receiving treatment to lower blood pressure: analysis of data from placebo controlled randomised controlled trial

Por Keenan, Katherine, Hayen, Andrew, Neal, Bruce C, Irwig, Les
Publicado em 2009

Model of outcomes of screening mammography: information to support informed choices

Por Barratt, Alexandra, Howard, Kirsten, Irwig, Les, Salkeld, Glenn, Houssami, Nehmat
Publicado em 2005

Designing studies to ensure that estimates of test accuracy are transferable

Por Irwig, Les, Bossuyt, Patrick, Glasziou, Paul, Gatsonis, Constantine, Lijmer, Jeroen
Publicado em 2002

Model of outcomes of screening mammography: Authors' reply

Por Barratt, Alexandra, Howard, Kirsten, Irwig, Les, Salkeld, Glenn, Houssami, Nehmat
Publicado em 2005

Patients who take their symptoms less seriously are more likely to have colorectal cancer

Por Adelstein, Barbara-Ann, Macaskill, Petra, Turner, Robin M, Irwig, Les
Publicado em 2012

An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population

Por McGeechan, Kevin, Macaskill, Petra, Irwig, Les, Bossuyt, Patrick MM
Publicado em 2014

Use of randomised trials to decide when to monitor response to new treatment

Por Bell, Katy J L, Irwig, Les, Craig, Jonathan C, Macaskill, Petra
Publicado em 2008

A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult

Por Towler, Bernie, Irwig, Les, Glasziou, Paul, Kewenter, Jan, Weller, David, Silagy, Chris
Publicado em 1998

n of 1 trials in osteoarthritis: Authors’ reply

Por March, Lyn, Schwarz, Jennifer, Irwig, Les, Simpson, Judy, Chock, Catherine, Brooks, Peter
Publicado em 1995

Most bowel cancer symptoms do not indicate colorectal cancer and polyps: a systematic review

Por Adelstein, Barbara-Ann, Macaskill, Petra, Chan, Siew F, Katelaris, Peter H, Irwig, Les
Publicado em 2011

The value of age and medical history for predicting colorectal cancer and adenomas in people referred for colonoscopy

Por Adelstein, Barbara-Ann, Macaskill, Petra, Turner, Robin M, Katelaris, Peter H, Irwig, Les
Publicado em 2011

The reliability of a quality appraisal tool for studies of diagnostic reliability (QAREL)

Por Lucas, Nicholas, Macaskill, Petra, Irwig, Les, Moran, Robert, Rickards, Luke, Turner, Robin, Bogduk, Nikolai
Publicado em 2013

Which lipid measurement should we monitor? An analysis of the LIPID study

Por Glasziou, Paul P, Irwig, Les, Kirby, Adrienne C, Tonkin, Andrew M, Simes, R John
Publicado em 2014